NEW YORK (GenomeWeb News) – BioTek Instruments has struck a co-marketing agreement with the specialty assay developer Gyrasol, under which the companies will jointly promote an assay platform with a microplate reader, BioTek said today.
Under the agreement, the companies will promote the Gyrasol Sensor, a fluorescence-based assay platform, on BioTek’s Synergy 4 Hybrid microplate reader.
The Gyrasol Sensor is used in screening for kinases and phosphatases in a homogeneous format, and the BioTek microplate reader combines filter-based and monochromator-based fluorescence detection in one unit, BioTek said. The Synergy microplate reader offers multi-detection for “an unlimited number of current and future microplate-based assays,” the company said.
Further terms of the alliance were not disclosed.